Literature DB >> 16059774

Recombinant parathyroid hormone in the management of osteoporosis.

J Compston1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16059774     DOI： 10.1007/s00223-005-0012-0

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN： 0171-967X            Impact factor:   4.333


× No keyword cloud information.
  4 in total

1.  Bone quality of the newest bone formed after two years of teriparatide therapy in patients who were previously treatment-naïve or on long-term alendronate therapy.

Authors:  B Hofstetter; S Gamsjaeger; F Varga; H Dobnig; J J Stepan; H Petto; I Pavo; K Klaushofer; E P Paschalis
Journal:  Osteoporos Int       Date:  2014-07-19       Impact factor: 4.507

Review 2.  Effectiveness of Teriparatide on Fracture Healing: A Systematic Review and Meta-Analysis.

Authors:  Zhongju Shi; Hengxing Zhou; Bin Pan; Lu Lu; Jun Liu; Yi Kang; Xue Yao; Shiqing Feng
Journal:  PLoS One       Date:  2016-12-20       Impact factor: 3.240

Review 3.  The effectiveness and safety of parathyroid hormone in fracture healing: A meta-analysis.

Authors:  Hao Hong; Ting Song; Yang Liu; Jun Li; Qilong Jiang; Qizhi Song; Zhongliang Deng
Journal:  Clinics (Sao Paulo)       Date:  2019-04-25       Impact factor: 2.365

Review 4.  The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders.

Authors:  Eugenia Bertoldo; Giovanni Adami; Maurizio Rossini; Alessandro Giollo; Giovanni Orsolini; Ombretta Viapiana; Davide Gatti; Angelo Fassio
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-21       Impact factor: 5.555
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.